Skip to main content
Equibles
EVH logo

EVH · Evolent Health, Inc.

Track EVH — free

Use EVH with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$4.32 +0.06 (+1.41%) At close · Sep 4
Russell 2000 member Rebalance outlook locked
Market Cap
$488.42M
Shares
113.06M

EVH metrics

62 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$4.32
Market cap
$488.42M

Price action

19 metrics
Price change (1W)
-6.1%
Price change (30D)
+20.3%
Price change (3M)
+2.4%
Price change (6M)
+36.3%
Price change (YTD)
+8.0%
Price change (1Y)
-54.5%
Trailing year
Price change (5Y)
-83.5%
52-week high
$9.99
52-week low
$2.17
Change from 52-week high
-56.8%
Change from 52-week low
+99.1%
Annualized volatility
80.8%
Beta
0.9
RSI (14D)
46.5
Price vs SMA 50
-8.5%
Price vs SMA 200
+12.0%
Avg volume (3M)
3.05M
Relative volume
0.6
Average dollar volume
$13.84M

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
113.06M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.2×
reciprocal yield 438.5%
P / book
1.2
reciprocal yield 80.1%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
8.8
reciprocal yield 11.4%
Earnings yield
-105.6%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.5×
reciprocal yield 65.1%
EV / revenue historical average (5Y)
1.5×
reciprocal yield 65.1%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
17.2%
Operating margin
-20.4%
Trailing 12 months
Net margin
-24.1%
Gross profit (TTM)
—
Operating profit (TTM)
−$427.50M
Net income (TTM)
−$504.99M
Trailing 12 months
Diluted EPS (TTM)
$-4.57
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+46.9%
Year over year
Net income growth YoY
—
Revenue (TTM)
$2.10B
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-2.9%
Year over year · fewer shares
Revenue CAGR (3Y)
+11.5%
Revenue CAGR (5Y)
+15.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-131.8%
Return on assets
-25.6%
Debt / equity
—
Current ratio
1.2
EBITDA (TTM)
−$315.73M
Free cash flow (TTM)
—
Quick ratio
1.2
Interest coverage
-6.2
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$115.70M
Total assets
$1.97B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$54.32M
Capital expenditures (TTM)
$35.53M
R&D (TTM)
—
SG&A (TTM)
$291.90M
Stock compensation (TTM)
$42.93M
R&D / revenue
—
Stock compensation / revenue
2.0%

Ownership (13F)

3 metrics
13F filers
200
13F filer change QoQ
+7
Institutional ownership
99.7%

Short interest

3 metrics
Short interest
14.0%
Latest settlement · 4.0 days to cover
Days to cover
4.0d
Short-squeeze score
69 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$329,460
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1628908 CUSIP 30050B101 13F (30d) 150 filings 148 filers Visit website Investor relations